Karishma Munoli

Introduction: The prevalence of pterygium shows a substantial increase for increasing age and UV irradiation. There is paucity of available literature regarding the total area of pterygium, percentage of extension of pterygium on to the cornea and its effects on corneal astigmatism. Hence this study was undertaken to evaluate the pre and post-surgical effect of the size of the pterygium on corneal astigmatism. Materials and Methods: 100 out patients aged between 22 to 50 years diagnosed with pterygium were included in the study. Slit lamp bio microscope was used to measure the length and width of pterygium in millimetres. Slit beam was used to measure the diameter of cornea. Corneal astigmatism was measured pre and postoperatively on day 1 and 1 month follow up using keratometery. Results: In this study 2.13±1.39 was the mean preoperative astigmatism, 1.36±1.03 was the mean post-operative astigmatism on day 1 and on 1 month follow up 0.86±0.91 was the mean post-operative astigmatism which was statistically significant(p Conclusion: As per our findings we draw a conclusion that surgical removal of pterygium significantly reduces pterygium induced astigmatism and also there is an improvement in visual acuity.   Keywords: Astigmatism, Cornea, Pterygium

Abstract Introduction: Ophthalmic complications are very common in tuberculous meningitis (TBM) patients, understanding the ocular problems in tubercular meningitis patients is very important for ophthalmologists to intervene on time to prevent irreversible damage to eye. Hence this investigation has been undertaken to study ophthalmic manifestations in suspected tubercular meningitis patients in both Pediatric and adult population in Basaveshwara teaching and general hospital, Kalaburagi attached to Mahadevappa Rampure Medical College (MRMC). Materials and Mathods: The study was conducted at Basaveshwara Teaching and General Hospital, Kalaburagi attached to M.R. Medical College, from Dec 2011 to May 2013. 100 admitted patients diagnosed with TB meningitis, were selected for the study. The patients were divided into 2 groups. Group A consisted of TBM patients who were conscious and cooperative for ophthalmic examination. Group B consisted of TBM patients who were in a state of coma, uncooperative for ophthalmic evaluation. Results: Out of the 100 patients, 64% had ocular findings. In our study 22% had cranial nerve palsy. Fundus changes were seen in 50% of the patients. Around 22% patients had visual acuity, CSF protein content was considerably high in all patients. Hydrocephalous was seen in 31% (20) patients. Conclusion: In our study it was observed that most of TBM patients had ocular findings, CSF protein was found in many patients and after treatment there was improvement in ocular problems. We suggest further research with larger sample size to support our findings. Keywords: Meningitis, Tuberculosis, Ophthalmic manifestations. Introduction Tuberculosis (TB) is still increasing in India at an alarming rate. The most serious form of tuberculosis is tubercular meningitis (TBM). [1]  TBM causes many complications in both children and adult patients. The close association between optic nerve and meninges produces many ocular problems. Commonly found ophthalmic complications in TBM are Optic neuritis, optic atrophy, papilloedema. It may be associated with lid retraction, tonic deviation of eyes, and pupillary abnormality in size. Patients with high CSF protein content are prone for primary optic atropy. Choroidal tubercles and papilloedema are signs of grave complications. [2] Ophthalmic complications are very common in tuberculous meningitis patients, so understanding the ocular problems in tubercular meningitis patients is very important for ophthalmologists to intervene on time to prevent its irreversible damage to the eye. Hence this study of ophthalmic manifestations in tubercular meningitis patients has been carried out to know the type of ophthalmic complications present in TBM patients. Materials and Methods The study was conducted at Basaveshwara Teaching and General Hospital, Kalaburagi attached to M.R. Medical College. The study period was from Dec 2011 to May 2013. 100 admitted patients referred from the Medicine, Pediatrics and Neurology department, diagnosed with TB meningitis, were selected for the study. Out of 100 cases selected, 80 were in the adult age group and 20 were from Pediatric age. Inclusion Criteria All sexes and any age Diagnosed cases of tubercular meningitis at Basaveshwara Hospital, Kalaburagi Exclusion Criteria Other causes of Papilloedema Viral infections Other causes of meningitis. Patients with significant cataractous changes in the lens Any other media opacities. A meticulous history was taken from all the cases, followed by a thorough ocular examination. Observations were made on the modes of presentation and a criterion was applied for diagnosis and the visual outcome in the individual patients. The following investigations were done in all patients Routine tests Haernoglobin Total Leucocyte count, differential leucocyte count Erythrocyte sedimentation rate Random blood sugar Chest X-ray Sputum for AFB in symptomatic patients Urine routine Peripheral Smear for blood picture Peripheral smear for malaria parasite CSF Examination Appearance Protein Sugar Total Count Differential count AFB staining Culture and sensitivity for pyogenic organisms CSF ADA level CSF Chloride CT scan-Brain, when needed and if feasib1e. Visual Acuity Testing Slit Lamp Examination Indirect Ophthalmoscopy Methods for clinical examination of the eye The visual acuity was recorded using Snellens visual acuity charts for each eye separately. The unaided acuity was first recorded followed by the best corrected visual acuity (BCVA) with a pin hole which was documented. Pupillary reactions checked for both direct and indirect light reflex. The anterior segment of the eye was examined under the slit lamp, for any manifestations of tubercular meningitis After dilating the pupils with phenylephrine (1 drop 2.5% 0r 10% for adults and children 1 drop 2.5%) every 3-5 minutes and tropicamide (1%) eye drops, posterior segment examination was done with direct ophthalmoscopy and also by binocular indirect ophthalmoscopy Fundus examination with 78D and 90D Volk lenses was also done Clinical findings were recorded in a proforma sheet Patients were referred back to the medicine and pediatric department for further treatment. Children below the age of three and those unco-operative for vision were tested depending upon whether they reacted to the light source and whether they followed the light source projected onto their eyes, thus confirming their ‘PLPR’ status (perception of light-PL; projection of rays-PR). For patients where visual acuity couldn’t be tested (unconscious/ventilated), outcome was based upon their pupillary reactions and their fundus findings. A little older children and those co-operative for vision were tested by Snellens chart or were tested depending upon whether they followed the light/objects in front of them. Their families were asked about the child’s facial recognition, social smile and how he responded to objects at home. Treatment of tubercular meningitis All patients in the pediatric age group, diagnosed with TBM were given the following treatment. Prior to starting the treatment, following investigations were done- Complete blood count Mantoux test Chest x-ray Lumbar puncture- TC, DC, Protein, Sugar, ADA, Chloride. CT Brain Liver Function Test (LFT). Treatment ATT Drugs: Intensive phase consisted of 4 drug combination- HRZE H- Isoniazid: 10 mg/kg/day R- Rifampicin; 10 mg/ kg/day. Z- Pyrazinamide: 20 mg/kg/day E- Ethambutol: 25 mg/kg/day. HRZ (Macox-ZH Kid Plus) was given for 2 months duration. After the intensive phase was completed three drug combinations consisting of HRZ was continued for a period of 7 months. Tab Prednisolone- 2 mg/ kg/day for 6 weeks followed by which the drug was tapered off in 2 weeks. IV Mannitol — 5 mi/kg was given for 3 days. Tab pyridoxine —40 mg/ kg. Anticonvulsants were given in case the child had seizures Eg- tab phenobarbitone (adults; 60-180mg daily at night. children; 2.5-4mg/kg once or twice daily). Follow-up The patient was reviewed after 15 days of discharge from the hospital and called in every month thereafter till the course of treatment was completed. LFT was done after 15 days of starting on ATT drugs and repeated at 1 month follow-up. Treatment regime in adults After the routine investigations were done (as mentioned above) and the patient diagnosed as TBM, the following treatment was started: Tab Forecox — consisting of HRZE was given for 6 months in the dose of 2-0-0. H—300mgOD R—600rngOD Z-l.5 gOD E—1.5 mg/kg/day’. If the weight of the patient is < 30> IV Dexarnethasone 8mg/kg TID is started along with the ATT drugs. Tab Eptoin- 100 rng for 3 months for epilepsy. Follow- up Patients were called for a monthly follow up and then bi-rnonthly follow up till the symptoms subsided. Statistical Analysis Risk factors for development of oculo-visual anomalies were compared with chi square test Difference in proportions was tested by chi square test. Results A total of 100 admitted patients diagnosed with tubercular meningitis were taken up for this study. The patients were divided into 2 groups. Group A consisted of TBM patients who were conscious and cooperative for ophthalmic examination. Group B consisted of TBM patients who were in a state of coma, uncooperative for ophthalmic evaluation Table 1: Total study group patients divided into groups Group Patients Percentage A 88 88 B 12 12 Total 100 100 Out of the 100 patients, 64% had ocular findings: Out of the 88 patients in group A, 52(59.09%) patients had ocular manifestations and remaining 36 (40.9%) showed no ocular manifestations. Table 2: Age & sex wise distribution of study population Age Sex Total % Males % Females % 0-14 16 31.4 14 28.6 30 30 15-20 04 7.84 10 20.4 14 14 21-30 11 21.6 16 32.6 27 27 31-40 09 17.6 05 10.4 14 14 41-50 05 9.80 02 4.08 07 07 51-60 06 11.8 02 4.08 08 08 Total 51 100 49 100 100 100 Males constituted 51(51%) of the total cases while females constituted 49(49%). Majority i.e 55(55%) were in the age group between 15-40 years of age. 30(30%) were in the pediatric age group and 15(15%) were in the age group between 4 1-60 years. Mean age of males is 24.26±12.52 Mean age of females is 24.404±13.64As the p> 0.05, the difference in the age distribution of cases among males and females is not significant. Table 3: Visual acuity of study population S. No Visual acuity Total Percent 1 6/6-6/8 61 61 2 10 10 3 05 5 4 07 7 5 NO PL 05 5 6 Not rec. 12 12   Total 100 100 Majority of the patients had near normal vision at presentation (61%) There were 22(22%) patients who had visual deficit at presentation. There were 5(5%) patients who presented with loss of vision in either eye. Visual acuity could not be assessed in 12(12%) patients as they presented in a state of unconsciousness/unco-operative and hence further assessment was made on the basis of pupillary reactions and fundus findings. Table 4: Cranial nerve palsy in study populations S. No Cranial nerve Male Female Total 1 III: Complete Incomplete 1 1 6 2 2   2 VI: Unilateral Bilateral 6 6 13 1 0 3 VII 00 01 01 4 Combined 02 04 06   Total 10 10 22 Cranial nerve palsy was seen in 22(22%) patients It was observed that, out of the 22, maximum patients had VI Cranial Nerve Palsy 13% Followed by the VI nerve was the involvement of III Cranial nerve of 6%. VII nerve involvement was seen in only 1%. Combined nerve involvement was seen in 6%. Combined nerve palsy was often seen in association with 2’nerve involvement (5out 6). II and VI nerve constituted 4 patients II and III nerve constituted 2 patients III and VI nerve involvement was seen in 1 patient. The p value is more than 0.05 which shows that there is no significant difference in the cranial nerve palsies between males and females. Click here to view Fig. 1: Multiple Bar presents cranial nerve palsies Table 5: Fundus findings S. No Features Patients Total % 1. Normal 50 50 50 2. Papilloedema 21 21 21 3. Papillitis 12 12 12 4. Temporal pallor: Bilateral 05 05 05 5. Total OA: Primary Secondary   05 07   12   12   Total 100 100 100 Fundus changes were seen in 50(50%) of the patients. Papilloederna was seen as the most common finding, in 21% of patients and Papillitis constituted 12%. Blindness occurring secondary to optic atrophy. Optic atrophy occurred as post-papilloedema/papillits (secondary) or as primary optic atrophy. Optic atrophy was either complete (total pallor of disc) or incomplete (temporal pallor). Optic atrophy in the form partial atrophy was 05(5%) Total Optic atrophy was seen in 12(12%) Table 6: Pupillary findings S. No Pupillary changes No % 1 Sluggish 27 56.25 2 Anisocoria 03 6.25 3 Fixed dilated 02 4.17 4 RAPD (grade 3-4) 16 33.33   Total 48 100 Table 7: Visual field changes S. No Visual field findings Patients (n) % 1 Normal 34 34 2 Enlargement of blind spot 5 5 3 Peripheral constriction 6 6 4 Scotoma 4 4 5 Not recordable 15 15 6 Not done 36 36   Total 100 100 The above findings were in regards to the worse affected eye. Out of the 100, static perimetry was done only in patients with stage II and III.         Out of the 64 patients, in 34 patients, perimetry was normal. 5 patients showed enlargement of blind spot. 6 patients showed peripheral constriction of the visual field. 3 patients showed central scotoma and 1 patient showed centrocecalscotoma. In 15 patients, perimetry could not be recorded because they were in stage III, unco-operative/ unconscious state and those who showed complete optic atrophy, visual field testing is not possible.        Table 8: CSF findings S.no CSF parameters Patients (n) Patients (n) Percentage   1 Protein (mg/1)         a) 0 0 c12=12.35 (p significant   b)51-100 8 8   c) 101-300       d)>300     2 Glucose (mg/dl)     c2=14.86 (p   a) 0-40 80 80   b)41-70 17 17   c) >70 3 3 3 Cells/mm3     c2=11.76 (p   a)0-20 0 0   b) 21-100 50 50   c) 101-200 18 18 Significant   d) 201-300 20 18   e) >300 12 12 4 Low CSF chloride ( 67 67   A lower level of glucose (70mg/dl The mean value of glucose was 80% of the cases who had a cobweb appearance of CSF and protein was found to be elevated in all cases. 27 cases had >300 mg CSF protein, max being 2g. The mean value of protein was CSF cells were elevated in all cases All cases had >60% lymphocyte predominance. Table 9: CT scan findings S.no CT Findings No. of Patients 1 Normal 32 2 Hydrocephalus 21 3 Basal exudates 5 4 Basal infarcts 5 5 Tuberculoma 1 6 Cerebral edema 2 7 Not done 34 CT scan was done in 66 patients. Out of the 66 patients, maximum patients i.e 21(31.8%) had Hydrocephalus. Basal Meningitis was seen in 10(15.15%) patients. Tuberculorna was found in 1(1.51%) patient. Cerebral edema was seen in 2(3.03%). CT scan was not done in 34 patients. Table 10: Risk factors for potential ocular abnormalities S. No Risk factors No. of cases Percentage 1 Delayed presentation 64 64 2 Protein levels       0 0   51-100- 8 8   100-300- 65 65   >300- 27 27 3 Hydrocephalous 20 20 4 Interrupted treatment 1 1 The above table shows that more than half of the patients had ocular manifestations. i.e 64 out of 100 patients The protein content was considerably high in all patients Hydrocephalous was seen in 20 patients.   Risk factor Group A Mean±S.D Group A2 Mean±SD Group B Mean±SD t-test and p comparsion CSF Sugar 33.80±15.5 30.5±12.46 33.0±17.12 A1&A2:p>0.0 A2&B:p>0.0 A1&B:p>0.0 CSF Protein 128.67±125.75 283.58±157.82 549.5±122.14 A1&A2:p>0.0 VHS A2&B:p>0.0 A1&B:p>0.0 P CSF Cells/mm 92.27±46.37 171.23±123.82 249.41±103.95 A1&A2: p>0.001; VHS A2&B:p>0.0 A1&B: p>0.001, VHS CSF chloride 17.55±10.75 90.96±25.3 96.58±17.46 A1&A2: p>0.001; VHS A2&B:p>0.0 A1&B: P VHS CSF ADA 13.0±6.63 13.59±7.3 16.98±5.38 A1&A2: p > NS AD&B: P A1&B: p Hydrocephalus 0 12 9 c2=17.5, p The above table shows the comparison of risk factors for oculo-visual anomalies between the three groups. Group A has been divided further into Al & A2 where Al consists of 36(36%) patients without any ocular manifestations. A2 consists of 52(52%) patients with ocular manifestations. It is clear that there is significant difference in the severity of risk factors between the groups with group B having a higher risk of ocular anomalies than group A and Group A2 a higher risk than Al. S- Significant HS- Highly Significant VHS- Very Highly Significant NS- Not Significant. Table 11: Visual outcome after treatment S. No Visual acuity At 1 month At 3rd month 1 >6/18 69 66 2 < 6> 18 14 3 < 6> 18 14   No PL 7 8   Total patients 94 88 Six patients were lost (death) during the period of stay in the hospital, thus only 94 patients were available for 1 month follow-up. At 3’ month, additional 6 patients were lost as they did not turn up for follow-up visit. Thus 3’’ month follow up included 88 patients.   S. No Fundus At 1 month At 3rd month 1 Papilloedema 5 0 2 Papillitis 12 0 3 Partial optic atrophy 3 9 4 Total optic atrophy 7 8   Total 94 88 Group wise comparison of outcome Visual outcome Group A Group B Total Normal 29 0 29 Improved 38 0 38 Not improved 14 7 21 Expired 1 5 6 Did not turn up 6 0 6 Total 88 12 100 The above table shows that mortality rate and poor visual outcome is more amongst group B population. i.e Stage III of Tubercular Meningitis. Out of the 12 patients who presented in stage III, 5(41.66%) expired during their stay at the hospital and 7(58.33%) had oculovisual anomalies. c2= 15.26, p Discussion In our study out of 100 TBM patients 64% had ocular manifestations, Verma et al,[3] investigated 50 cases of pediatric tubercular meningitis, they observed that 76% had ophthalmic problems. There was frequent involvement of third nerve and sixth cranial nerve. It’s been observed that highest incidence of mortality was with sixth nerve palsy which is followed by a complete third canial nerve palsy. In our study 22% had cranial nerve palsy in that 13% had 6 nerve palsy and 6% had 3rd nerve palsy, Lamba PA et al carried out a study on 48 children with TBM, in which Optic disc changes (papillitis) constituted 62%, papillary involvement was in 48% of patients and cranial nerves (3rd) involvement was found in 28% of patients.[4] 22% had visual acuity, 21% had papilloedema, 12% had papillitis Mishra M, et al, carried out study on 100 patients with T.B. meningitis, 82% of patients had ocular complications in which 40% presented with diminished visual acuity, 22% had papilloedema, 25% presented with ocular paresis, 18% had pale disc and 10% choroidal tubercles.; 22% had evidence of obstructive hydrocephalus diagnosed by ventriculogram/C.T, 20% cases had vasculitis diagnosed by angiography and 12% of patients had Tuberculoma.[5] In our findings 80% percent showed low level of CSF glucose, 27 cases had CSF protein more than 300mg and CT scan was done in 66 patients out of this 21(31%) had hydrocephalus, basal meningitis was seen in 15%, tuberculoma was observed in 1.5% and cerebral edema was found in 3% of patients. Sinha et al, conducted study on 101 patients of T.B. meningitis, in which at the study enrolment 74 patients had normal vision and 27 patients presented with low vision. During the process of study 13 patients died and remaining 88 patients who survived at 6 months, in 88 survived patients 68 patients had good vision, 11 patients presented with low vision and 9 patients had presented with blindness. Papilloedema, cranial nerve palsies, raised cerebrospinal fluid protein (> 1 g/L), and presence of optochiasmatic arachnoiditis in MRI diagnosis were predictors of vision deterioration. The predictors of blindness at 6 months were observed to be papilledema, vision acuity 1 g/L), optochiasmatic arachnoiditis, and optochiasmal tuberculoma.[6] Benneggi A et al, found a case with severe ocular manifestations in a patient with tuberculous meningitis.[7]  Anupriya A et al carried out a study on 163 patients and had observed that Optochiasmatic Arachnoiditis may occur as a complication of T.B. meningitis.[8] Smith et al, found that tuberculosis was mediating factor in acquired abducens nerve palsy in children.[9] In our investigation visual acuity improved from 1month post-operative period to 3rd month post-operative period, fundus changes like papilloedema and papillitis became nil after 3rd month post-operative period. Mortality rate and poor visual outcome was found more amongst stage III TBM patients. It is clear that there is significant difference in the severity of risk factors between the groups with group B having a higher risk of ocular anomalies than group A. In our study it was observed that most of TBM patients had ocular findings. Timely intervention for TBM can prevent severity of ocular problems. We suggest further research with larger sample size to support our findings Conflict of interest: None. Financial support: None.   References ^ Das U, Gupta VK, Yadav P, Mediratta V, rewash BB. Tuberculous meningitits with blindness, jiacm 2010;11(1):61-62 ^ Choudhary M, Shah DN, Sharma PR. Ocular manifestations of meningitis in children. j Nepal paediatr soc.2012;32(2):136-141. ^ Verma BMD, Srivastav SK, Srivastav JR. Ocular manifestation of tubercular meningitis and their prognostic value in children. IJO 1981;29:301-302. ^ Lamba PA, Bhalla JS, Mullick DN-Ocular Manifestations of tubercular meningitis-A clinico-biochemical study.PMID-3723294. J pediatr ophthalmol strabismus 1986;23(3):123-125. ^ Mishra M, Rath S, Acharya BN, Mohanty S, Panigrahi BP. Neuro-ophthalmic profile in TBM. Ind J Tub 1985;23:142. ^ Sinha MK, Anuradha HK Atul Aggarwal A. Vision Impairement in Tuberculous meningitis, Journal of neurological sciences. 2010; 290(1): ^ Benneggi A, Adamoli P, Bernardini E, Branchi M-A case with severe ocular manifestations in a patient with tuberculous meningitis.PMID-8685007. Pediatr Med Chir 1995;17(5):465-469. ^ Anupriya A, Sunidhi M, Maya T, Goel M, Alexander M, Aaron S-Tuberculous Optochiasmatic Arachnoiditis. Neurology Unit,CMC Vellore. Neurol India 2010;58(5):732-735. ^ Smith DE, Blasi A. 6th nerve palsy secondary to tuberculosis. Optom 2009;80(10):567-571.